Breaking News, Collaborations & Alliances

Transpire Bio, Recipharm Partner for the Development of an Inhaled Medicine

To develop TRB-1 and TRB-2, inhaled medicines for the treatment of asthma and chronic obstructive pulmonary disease.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has formed an agreement with Recipharm to develop TRB-1 and TRB-2, inhaled medicines for the treatment of asthma and chronic obstructive pulmonary disease (COPD). TRB-1 and TRB-2, the first products developed by Transpire Bio will be indicated for the treatment of asthma and COPD, intended for advanced markets. “Our mission is to improve access to import...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters